US 7507826
Azaindoles useful as inhibitors of JAK and other protein kinases
granted A61KA61K31/437A61K31/444
Quick answer
US patent 7507826 (Azaindoles useful as inhibitors of JAK and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/437, A61K31/444, A61K31/496, A61K31/506